Journal article
Intravitreal bevacizumab in inflammatory ocular neovascularization
Ahmad M Mansour, Friederike Mackensen, J Fernando Arevalo, Focke Ziemssen, Padmamalini Mahendradas, Abla Mehio-Sibai, Nicholas Hrisomalos, Timothy YY Lai, David Dodwell, Wai-Man Chan, Thomas Ness, Alay S Banker, Sivakami A Pai, Maria H Berrocal, Rania Tohme, Arnd Heiligenhaus, Ziad F Bashshur, Moncef Khairallah, Khalil M Salem, Frank N Hrisomalos Show all
AMERICAN JOURNAL OF OPHTHALMOLOGY | ELSEVIER SCIENCE INC | Published : 2008
Abstract
PURPOSE: To assess the role of bevacizumab in inflammatory ocular neovascularization. DESIGN: Retrospective, multicenter, consecutive case series of inflammatory ocular neovascularization. METHODS: Patients with inflammatory ocular neovascularization of varying causes for whom standard therapy failed were treated with intravitreal injection of bevacizumab. Main outcome measures included improvement of best-corrected visual acuity (BCVA) expressed in logarithm of minimum angle of resolution units, response of inflammatory ocular neovascularization by funduscopy and angiography, and decrease in central foveal thickness as measured by optical coherence tomography at the three-month follow-up. R..
View full abstract